Quote:
February 3, 2026: Regular Abstract Scheduling Notifications Sent (2 p.m. ET)
February 10, 2026: Submission Deadline: Final Data for Clinical Trial Placeholder Abstracts
February 17, 2026: Manuscript Submission Deadline for Simultaneous Publication Consideration (Late-Breaking and Clinical Trials Abstracts)
February 17, 2026: Late-Breaking and Clinical Trials Abstract Notifications Sent
Suspect it is a Clinical Trial abstract, since it details either "clinical results" or "biomarkers" measured in the CRC trial.